Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Paclitaxel + Carboplatin in Metastatic Melanoma
NCT01014351Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in melanoma, sponsored by SCRI Development Innovations. Started Feb 2010; status: completed.
02
Drugs
everolimus
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01014351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014351.